通过免疫组合疗法治疗晚期肝细胞癌的进展
Di Pan1, Hao-Nan Liu1, Peng-Fei Qu2
1Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China.
World journal of gastrointestinal oncology
|March 1, 2024
概括
晚期肝细胞癌 (HCC) 治疗正在通过免疫疗法发展. 免疫检查点抑制剂和其他新疗法显示出希望,为这种严重肝癌患者提供了新的希望.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 晚期肝细胞癌 (HCC) 是一个重大的全球健康挑战,通常在晚期被诊断出来,限制了治愈治疗选择.
- 瘤细胞拥有逃避宿主免疫系统的机制,使治疗效率复杂化.
- 癌症免疫疗法的近期突破为HCC管理提供了有前途的治疗途径.
研究的目的:
- 审查目前针对高级HCC的免疫疗法策略的现状.
- 总结一下HCC免疫疗法的最新研究进展.
- 讨论新型免疫疗法在HCC治疗中的未来方向和潜力.
主要方法:
- 对HCC目前免疫治疗方法的文献综述.
- 分析免疫检查点抑制剂 (ICI),CAR T细胞疗法和癌症疫苗方面的研究进展.
- 对各种免疫疗法在HCC中的疗效和机制的综合数据.
主要成果:
- 免疫检查点抑制剂 (ICI),包括PD-1/PD-L1和CTLA-4抑制剂,已在HCC患者中改善了预后.
- 新兴的免疫疗法,如仿真抗原受体T细胞,工程细胞因子和癌症疫苗正在为HCC进行研究.
- 了解瘤免疫逃避机制对于开发有效的免疫治疗策略至关重要.
结论:
- 免疫疗法是一个快速发展的领域,具有显著的潜力,可以改善晚期HCC的结果.
- 对新型免疫治疗剂和组合策略的持续研究至关重要.
- 针对瘤特异性机制的个性化方法可能会提高HCC免疫治疗的有效性.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
761
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K